Melanoma

There are 317 papers on melanoma in aging research: 5 trials and 120 observational studies in people, 69 in animals, 31 in cells, 75 reviews. The newest story, Nov 7, 2026: “Heart risk scores underestimated risk after cancer immunotherapy”.

Disease

317 papers study it243 more mention it89 findings

MeSH

40 new papers in 30 daysSee all 560 papers on melanoma

At a glance

Melanoma risk is linked with older age and longer telomeres in human studies, and progression is associated with epigenetic aging programs in skin. An animal study reports that cellular senescence protects against melanoma after DNA double-strand breaks. A human aspirin trial shows no clear effect during randomized follow-up but reports lower melanoma risk during extended follow-up.

89 findings in 69 papers from 2005 to 2026, 18 of them since April 2026

“A reduced number of events was observed with aspirin among females in a subgroup analysis (HR = 0.65; 95% CI, 0.44-0.92); however, the interaction effect with males (HR = 0.92; 95% CI, 0.68-1.25) was nonsignificant (P = 0.17).”
Effect of Aspirin on Melanoma Incidence in Older Persons: Extended Follow-up of a Large Randomized Double-blind Placebo-controlled TrialCancer prevention research (Philadelphia, Pa.)2022doi:10.1158/1940-6207.capr-21-0244
  • Human trial5
  • Humans120
  • Animals68
  • Model organisms1
  • Cells31
  • In silico17

Interventions

13

Aspirin

no changein humans1HR 0.81

1 study
  1. Aspirin showed no clear effect on melanoma in humans during randomized trial period (HR 0.81, 95%CI 0.60-1.10).

    “The smaller number of events in the aspirin group was not statistically significant (HR 0.81, 95%CI 0.60-1.10, p=0.18).”

    Human trialduring randomized trial periodmedian trial follow-up of 4.7 yearsn = 19,114

    Effect of Aspirin on Melanoma Incidence in Older Persons: Extended Follow-up of a Large Randomized Double-blind Placebo-controlled Trial

    Cancer prevention research (Philadelphia, Pa.)

  2. Aspirin showed no clear effect on melanoma in humans (HR = 0.81; 95% CI, 0.60-1.10).

    “no significant effect of aspirin was observed on incident melanoma [HR = 0.81; 95% confidence interval (CI), 0.60-1.10]”

    Human trial100 mgmedian follow-up of 4.7 yearsn = 19,114

    Effect of Aspirin on Melanoma Incidence in Older Persons: Extended Follow-up of a Large Randomized Double-blind Placebo-controlled Trial

    Cancer prevention research (Philadelphia, Pa.)

More on Aspirin

Methylparaben

no changein humans1

1 study
  1. Methylparaben was not clearly linked with melanoma in humans.

    “whereas no significant associations were observed for melanoma”

    Humans

    Association between urinary paraben concentrations and skin cancer among US Adults

    Cancer epidemiology

More on Methylparaben

Chemotherapy

no changein humans1RR 0.9

1 study
  1. Chemotherapy was not clearly linked with melanoma in humans (childhood cancer survivors) (RR 0.9, 95% CI 0.5–1.6).

    “For chemotherapy, no statistically significant association was found (RR = 0.9, 95% CI = 0.5 to 1.6).”

    Humanschildhood cancer survivors

    Risk of subsequent primary melanoma in 68 002 five-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup cohort study

    Journal of the National Cancer Institute

More on Chemotherapy

Dietary vitamin D intake

no changein humans1

1 study
  1. Dietary vitamin D intake showed no clear effect on melanoma in humans.

    “No significant associations were observed for serum vitamin D concentration or dietary vitamin D intake in relation to melanoma risk.”

    Review

    Vitamin D and melanoma: an umbrella meta-analysis of serum levels, dietary intake, and VDR polymorphisms

    Journal of translational medicine

More on Dietary vitamin D intake

Dmvac

downin mice1

1 study
  1. Dmvac decreases melanoma in mice (melanoma in aged mice).

    “leading to significant suppression of tumor progression”

    Animalsmelanoma in aged mice

    A Biomimetic Nanovesicle-Based Synthetic Vaccine Platform Through Co-Anchoring Oxidized Phospholipid and CpG for Rejuvenating Antitumor Immunity in Aged Mice

    Angewandte Chemie (International ed. in English)

More on Dmvac

Interleukin-17

downin mice1

1 study
  1. Interleukin-17 decreases melanoma in mice (young B16-bearing mice).

    “exogenous IL-17 elicits αPD-L2 melanoma efficacy in young hosts”

    Animalsyoung B16-bearing mice

    Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling

    Nature communications

More on Interleukin-17

ANTI-PD-L2

downin mice1

1 study
  1. ANTI-PD-L2 decreases melanoma in B16-bearing mice.

    “αPD-L2 fails in young B16-bearing mice but is effective in aged.”

    Animalsin B16-bearing mice

    Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling

    Nature communications

More on ANTI-PD-L2

Bone marrow mononuclear cells

downin mice1

1 study
  1. Bone marrow mononuclear cells protect against melanoma in mice.

    “anti-cancer capability, in particular that against melanoma as well as hepatocellular carcinoma, and lifespan-extending property of Eklf(K74R) mice could be transferred to wild-type mice”

    Animals

    Long-term Hematopoietic Transfer of the Anti-Cancer and Lifespan-Extending Capabilities of A Genetically Engineered Blood System by Transplantation of Bone Marrow Mononuclear Cells

    eLifePreprint

More on Bone marrow mononuclear cells

ANTI-L1 vaccine

downin mice1

1 study
  1. ANTI-L1 vaccine decreases melanoma in mice (B16 melanoma models).

    “and suppressed lung metastasis in B16 melanoma models.”

    AnimalsB16 melanoma modelslung

    Naturally occurring T-cell-mediated antitumor immune response to LINE-1 antigens in mice that can be enhanced by vaccination and TLR5 agonist

    Research SquarePreprint

More on ANTI-L1 vaccine

Metformin

downin humans1

1 study
  1. Metformin inhibits melanoma in humans (skin neoplasms).

    “It has also shown antitumor properties regarding basal cell carcinoma, squamous cell carcinoma and melanoma.”

    Reviewskin neoplasms

    The role of metformin in the treatment of dermatological diseases: A narrative review

    Atencion primaria

More on Metformin

All 13

Effects

4

Mortality

downin humans1upin humans1

2 studies
  1. Melanoma is linked with lower mortality in high-SDI areas from 1990 to 2023.

    “In contrast, high-SDI areas exhibited stable incidence rates but declining mortality and disability-adjusted life year (DALY) rates.”

    Humansin high-SDI areas from 1990 to 2023

    Burdens of Malignant Melanoma and Projections for 2050 in Asia: Findings from the 2023 Global Burden of Disease Study

    Clinical, cosmetic and investigational dermatology

  2. Melanoma is linked with higher mortality in humans (Hungary 1980-2020).

    “crude mortality among older men continued to increase”

    HumansHungary 1980-2020males

    Temporal Trends of Melanoma and Non-Melanoma Skin Cancer Mortality Rates in Hungary Between 1980 and 2020

    Cancers

Malignant melanoma prevalence

upin humans1

1 study
  1. Melanoma is linked with higher malignant melanoma prevalence in East Asia.

    “The age distribution has shifted from the 45-64 age group to those aged 65 years and older, with individuals aged 75 and above dominating both prevalence and mortality rates in East Asia.”

    Humansin East Asia

    Burdens of Malignant Melanoma and Projections for 2050 in Asia: Findings from the 2023 Global Burden of Disease Study

    Clinical, cosmetic and investigational dermatology

More on Malignant melanoma prevalence

Malignant melanoma incidence

upin humans1

1 study
  1. Melanoma is linked with higher malignant melanoma incidence in humans (from 1990 to 2023).

    “From 1990 to 2023, age-standardized incidence rates (ASIR) increased across most of Asia, with the most pronounced positive EAPC values observed in low- and middle-SDI regions.”

    Humansfrom 1990 to 2023

    Burdens of Malignant Melanoma and Projections for 2050 in Asia: Findings from the 2023 Global Burden of Disease Study

    Clinical, cosmetic and investigational dermatology

More on Malignant melanoma incidence

Age-dependent telomere attrition

upin humans1

1 study
  1. Melanoma is linked with higher age-dependent telomere attrition in humans (P = .01).

    “Age-dependent telomere attrition was faster in melanoma cases than controls (P = .01).”

    Humans

    Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk

    Genes, chromosomes & cancer

More on Age-dependent telomere attrition

Upstream

6

Facial skin aging

no changein humans1

1 study
  1. Facial skin aging was not clearly linked with melanoma in humans (genetically determined).

    “no causal effect was found on malignant melanoma and squamous cell carcinoma”

    Humansgenetically determined

    Multi-omics Mendelian randomization revealing SEMA7A as potential drug target for facial skin aging

    Journal Of Big Data

Cellular senescence

downin mice1

1 study
  1. Cellular senescence protects against melanoma in response to DNA double-strand breaks.

    “McSCs undergo cellular senescence-coupled differentiation (seno-differentiation) in response to DNA double-strand breaks, resulting in their selective depletion and hair greying, and effectively protecting against melanoma.”

    Animalsin response to DNA double-strand breaks

    Antagonistic stem cell fates under stress govern decisions between hair greying and melanoma

    Nature cell biology

More on Cellular senescence

ICAM1

downin mice1

1 study
  1. ICAM1 decreases melanoma in mice (shown by blocking ICAM1).

    “blocking ICAM1 reduces tumor size and metastasis in older mice”

    Animalsshown by blocking ICAM1

    Age-dependent loss of HAPLN1 erodes vascular integrity via indirect upregulation of endothelial ICAM1 in melanoma

    Nature aging

More on ICAM1

ATM

no changein humans1

1 study
  1. ATM was not clearly linked with melanoma in humans (GWAS and genomics analyses).

    “demonstrated no association of this variant with any of these outcomes.”

    HumansGWAS and genomics analyses

    The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence

    International journal of molecular sciences

More on ATM

MIA

downin mice1

1 study
  1. MIA protects against melanoma in mice (shown by knockout in Tg(Grm1) melanoma model mice).

    “MIA-deficient mice supported the impact of MIA on senescence by showing a significantly earlier tumor onset compared to controls.”

    Animalsshown by knockout in Tg(Grm1) melanoma model mice

    Role of melanoma inhibitory activity in melanocyte senescence

    Pigment cell & melanoma research

More on MIA

Type I interferon signaling

downin cells1

1 study
  1. Type I interferon signaling decreases melanoma in IFN-deficient melanoma cells.

    “Restoration of IFN signaling in IFN-deficient melanoma cells induces senescence and suppresses melanoma progression.”

    Cellsin IFN-deficient melanoma cells

    Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression

    Cell reports

More on Type I interferon signaling

Associations

54

Telomere length

upin humans4OR 1.19

4 studies
  1. Telomere length is associated with melanoma in humans (Mendelian randomization using 5 telomere length-associated polymorphisms) (odds ratio 2.66 (95% CI 2.07–3.25)).

    “showed association between increased telomere length and melanoma risk with odds ratio of 2.66 (95% confidence interval: 2.07-3.25)”

    HumansMendelian randomization using 5 telomere length-associated polymorphisms

    Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk

    Genes, chromosomes & cancer

  2. Telomere length is linked with a higher risk of melanoma in humans (OR 1.19 (1.12-1.27)).

    “the per-allele odds ratio was 1.19 (1.12-1.27) for melanoma”

    Humansn = 95,568

    Long telomeres and cancer risk among 95 568 individuals from the general population

    International journal of epidemiology

  3. Telomere length raises the risk of melanoma in humans (pooled odds ratio: 0.51; 95% confidence interval: 0.38-0.69; P<0.0001).

    “Longer TL was significantly associated with an increased risk in melanoma (pooled odds ratio: 0.51; 95% confidence interval: 0.38-0.69; P<0.0001).”

    Review

    Telomere length and skin cancer risk: A systematic review and meta-analysis of melanoma, basal cell carcinoma and squamous cell carcinoma

    Oncology letters

  4. Telomere length raises the risk of melanoma in humans (observational association).

    “longer telomeres are associated with an increased risk”

    Reviewobservational association

    Skin phenotypes can offer some insight about the association between telomere length and cancer susceptibility

    Medical hypotheses

More on Telomere length

Older age

upin humans2

2 studies
  1. Older age is linked with a higher risk of melanoma in humans (Norway, 1980-2024) (>5% [5.2, 6.6]).

    “continued increases exceeding 5% [5·2, 6·6] in the oldest groups”

    HumansNorway, 1980-2024n = 60,722

    Melanoma incidence in Norway, 1980-2024: a cohort study

    The Lancet regional health. Europe

  2. Older age is associated with melanoma in Upper Silesia, Poland.

    “indicated irregularities of spatial variance in cutaneous malignant melanoma, especially in older women (≥60)”

    Humansin Upper Silesia, Polandfemales

    Recent Malignant Melanoma Epidemiology in Upper Silesia, Poland. A Decade-Long Study Focusing on the Agricultural Sector

    International journal of environmental research and public health

Ultraviolet radiation

upin humans2+90% new melanoma diagnoses

2 studies
  1. Ultraviolet radiation is associated with melanoma in humans (global burden).

    “Exposure to excess UVR is associated with approximately three-quarters of the global burden of melanoma.”

    Reviewglobal burden

    The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue

    The Journal of investigative dermatology

  2. Ultraviolet radiation raises the risk of melanoma in humans (up to 90% of new melanoma diagnoses).

    “Whilst up to 90% of new melanoma diagnoses are attributable to excess ultraviolet radiation”

    Review

    Melanoma: a genetics guide for surgeons

    Melanoma research

More on Ultraviolet radiation

Cardiovascular disease mortality

downin humans1upin humans1

2 studies
  1. Melanoma is associated with cardiovascular disease mortality in humans (melanoma diagnosis) (SMR = 0.79, 95% CI: 0.78, 0.81).

    “among people diagnosed with cancers with higher survival rates (e.g., Melanoma: SMR = 0.79, 95% CI: 0.78, 0.81)”

    Humansmelanoma diagnosis

    Cardiovascular Disease Mortality Patterns Among People With Cancer in New South Wales, Australia: A Population-Wide Data Linkage Study

    Cancer medicine

  2. Melanoma is linked with a higher risk of cardiovascular disease mortality in humans (malignant melanoma) (SMR 1.98 (95% CI 1.93-2.03)).

    “MM patients had a higher risk of CVD death than general populations (SMR = 1.98; 95% CI 1.93−2.03, p < 0.001).”

    Humansmalignant melanoma

    Risk of Cardiovascular Disease Death in Older Malignant Melanoma Patients: A Population-Based Study

    Cancers

Age

upin humans2

2 studies
  1. Age is associated with melanoma in humans (from 2014 to 2023) (+29.8% in region, +24.5% in cities, +58.6% in rural areas).

    “From 2014 to 2023, the incidence of melanoma increased by 29.8 % in the region, by 24.5 % in cities, and by 58.6 % in rural areas”

    Humansfrom 2014 to 2023skin

    Incidence of Melanoma Skin Cancer in the Elderly Population of the Samara Region

    ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT

  2. age raises the risk of melanoma in humans.

    “Age remains one of the greatest risk factors for melanoma”

    Review

    In the Wnt-er of life: Wnt signalling in melanoma and ageing

    British journal of cancer

Calendar time

upin humans2

2 studies
  1. calendar time is associated with melanoma in humans (1.8% and 1.5% increase).

    “Melanoma showed a 1.8% and 1.5% increase in melanoma incidence in individuals aged 45–64 years.”

    Humans2001-2019

    Long-term changes in melanoma epidemiology in Hungary: who are the high-risk groups, and where should we concentrate prevention programs?

    BMC public health

  2. calendar time is linked with a higher risk of melanoma in humans (overall population).

    “Early-stage diagnoses increased while the rates of late-stage diagnoses remained stable for the overall population.”

    Humansoverall population

    Examining Demographic, Geographic, and Temporal Patterns of Melanoma Incidence in Texas From 2000 to 2018: Retrospective Study

    JMIR cancer

Occupational sun exposure

downin humans1upin humans1RR 0.69–1.45

1 study
  1. Occupational sun exposure lowers the risk of melanoma in humans (when studies excluded LMM) (RR 0.69, 95% CI 0.55-0.86).

    “When studies excluded LMM the risk of melanoma was reduced (RR 0.69, 95% CI 0.55-0.86).”

    Reviewwhen studies excluded LMM

    Occupational Sun Exposure and Melanoma Development: A Review of the Evidence

    The Australasian journal of dermatology

  2. Occupational sun exposure raises the risk of melanoma in humans (when studies included the lentigo maligna melanoma (LMM) subtype) (RR 1.45, 95% CI 1.08-1.94).

    “The most robust pooled analysis suggested a 45% increase in the risk of melanoma with occupational exposure when studies included the lentigo maligna melanoma (LMM) subtype (relative risk (RR) 1.45, 95% CI 1.08-1.94).”

    Reviewwhen studies included the lentigo maligna melanoma (LMM) subtype

    Occupational Sun Exposure and Melanoma Development: A Review of the Evidence

    The Australasian journal of dermatology

More on Occupational sun exposure

Aspirin

downin humans1HR 0.65

1 study
  1. Aspirin lowers the risk of melanoma in humans (extended follow-up) (HR 0.65, 95%CI 0.44-0.97).

    “Subgroup analyses were repeated for the same characteristics, and a reduced number of melanoma events with aspirin amongst females (HR 0.65, 95%CI 0.44-0.97, p=0.03) but not males (HR0.65, 95%CI 0.44-0.97) was observed, however, the corresponding interaction effect was non-significant.”

    Human trialextended follow-upmedian trial follow-up of 4.7 years

    Effect of Aspirin on Melanoma Incidence in Older Persons: Extended Follow-up of a Large Randomized Double-blind Placebo-controlled Trial

    Cancer prevention research (Philadelphia, Pa.)

  2. Aspirin lowers the risk of melanoma in humans (HR = 0.65; 95% CI, 0.44-0.92).

    “A reduced number of events was observed with aspirin among females in a subgroup analysis (HR = 0.65; 95% CI, 0.44-0.92); however, the interaction effect with males (HR = 0.92; 95% CI, 0.68-1.25) was nonsignificant (P = 0.17).”

    Human trial100 mgfemales

    Effect of Aspirin on Melanoma Incidence in Older Persons: Extended Follow-up of a Large Randomized Double-blind Placebo-controlled Trial

    Cancer prevention research (Philadelphia, Pa.)

More on Aspirin

Obsessive-compulsive disorder

downin humans1HR 0.67

1 study
  1. Obsessive-compulsive disorder is associated with melanoma in humans (Swedish cohort) (HR 0.67, 95% CI 0.51–0.89).

    “In Sweden, OCD was associated with a lower risk of prostate cancer (HR 0.79, 95% CI 0.65–0.97) and melanoma (HR 0.67, 95% CI 0.51–0.89).”

    HumansSwedish cohort

    Cancer morbidity and mortality in individuals with obsessive-compulsive disorder: a population-based and sibling cohort study in Sweden and Denmark

    BMC medicine

More on Obsessive-compulsive disorder

Brain age gap

upin humans1

1 study
  1. Melanoma is associated with brain age gap in humans (treated melanoma patients compared with healthy controls) (4.67 vs. -0.57 years).

    “Melanoma patients showed elevated BAG relative to controls (4.67 vs. -0.57 years)”

    Humanstreated melanoma patients compared with healthy controlsbrain33 malessn = 64

    CNSC-50 Cortical brain aging reveals treatment- and sex-dependent effects in melanoma patients

    Neuro-Oncology

More on Brain age gap

All 54

Trial sponsors

Funding

34 grants since 2017

National Cancer Institute$34.3MUS Department of Veterans AffairsMelanoma Research Alliance290K

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies describe melanoma risk prediction and missed melanomas during self-skin examination among surfers and outdoor swimmers. Melanoma increases mortality in males in Hungary during 1980–2020; methylparaben has no effect on melanoma. Reviews link red hair and atypical moles to melanoma risk, with the mole association reported in fair-skinned patients with high cumulative sun exposure.

  2. Summary written from the findings.

Latest

Dec 2025: 8Jan 2026: 20Feb 2026: 22Mar 2026: 24Apr 2026: 6May 2026: 6Jun 2026: 10Jul 2026: 12Aug 2026: 21Sep 2026: 18Oct 2026: 23Nov 2026: 22192 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Heart risk scores underestimated risk after cancer immunotherapy

Among patients rated low risk, heart attacks and strokes occurred at 8.0-fold and 6.5-fold the rates predicted by two standard calculators.Among patients rated low risk, heart attacks and strokes occurred at 8.0-fold and 6.5-fold the rates predicted by two standard calculators.

Cohort · 23,727 peopleCancer
AHA Scientific Sessions 2026 Abstract

Renin-angiotensin system inhibitors linked to fewer deaths

After catheter-based aortic valve replacement, deaths occurred in 21.9% of people prescribed the drugs versus 27.4% of non-users over a median follow-up of 713 days.After catheter-based aortic valve replacement, deaths occurred in 21.9% of people prescribed the drugs versus 27.4% of non-users over a median follow-up of 713 days.

See all 560 papers on melanoma